Clinical Trials

For some patients, clinical trials offer a source of hope that a new treatment will provide the medical intervention they need to win their battle against cancer. These treatment trials also provide the critical research necessary to continue the search for a cure.

Cancer patients treated in well-organized clinical trials, in general, do as well or better than patients receiving "standard" treatments, particularly in difficult cancers where traditional treatments have not had a high success rate.

Experiencing tremendous growth since its establishment, the Penn State Hershey Cancer Institute at Mount Nittany Medical Center continues to participate in clinical research.

Contact Information

Please direct any questions to a Penn State Hershey Cancer Institute trials office staff member:

Breast

E2112:
A Randomized, Phase III Trial of Endocrine Therapy plus Etinostat/Placebo in Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer. E2112 Clinical Abstract (PDF)
S1207:
Phase III Randomized Placebo Controlled Clinical Trial Evaluting the use of Adjuvent Endocrine Therapy +/- One Year of Everolimus in Patients with High Risk Hormone Receptor Positive and Her2 Negative Breast CancerTrial of Endocrine Therapy plus Etinostat/Placebo in Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer. S1207 Clinical Abstract (PDF)
NRG-BR003:
A Randomized Phase III Trial of Adjuvent Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer. NRG-BR003 Clinical Abstract (PDF)
A011401:
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer. A011401 Clinical Abstract (PDF)

GI

There are no trials at this time.
 

Thoracic

A151216:
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). A151216 Clinical Abstract (PDF)
A081105:
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Recptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC). A081105 Clinical Abstract (PDF)
E4512:
A Phase III Double-Blind Trial for Surgically Resected Early State Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein (An Alchemist Treatment Trial). E4512 Clinical Abstract (PDF)
EA5142:
Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers. E5142 Clinical Abstract (PDF)

Leukemia

There are no trials at this time.

Lymphoma

There are no trials at this time.

Multiple Myeloma

There are no trials at this time.
 

Hematology

Dr. Zheng - Collection of Blood for Investigation and Characterization of Circulating Tumor Cells (CTCs) in Cancer Patients with Microdevices Clinical Abstract (PDF)

Head & Neck

There are no trials at this time.

Melanoma

There are no trials at this time.

Prevention

There are no trials at this time. 

GU

There are no trials at this time.

GYN

There are no trials at this time.

Barbara Gutch, RN, OCN
Clinical Research Coordinator
Phone: 814.231.7843
Fax: 814.231.7039
Email:bgutch@mountnittany.org

Shannon Fisher, RN
Clinical Research Coordinator
Phone: 814.231.7813
Fax: 814.231.7039
Email: sfisher@mountnittany.org